ArticleCancer medicine2014

HER2 overexpression a major risk factor for recurrence in pT1a-bN0M0 breast cancer: results from a French regional cohort.

Philippe Rouanet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.